Study reveals limitations in evaluating gene editing technology in human embryos

OHSU-led research identifies new scientific hurdles in using gene repair to prevent inherited disease

By Erik Robinson March 07, 2023 Portland, Oregon

Lea esta página en español

Downloads

Video download - Interview with Shoukhrat Mitalipov

Interview with Shoukhrat Mitalipov, Ph.D., in the Mitalipov lab at OHSU. (OHSU/Sara Hottman)

Download: B-Roll - Shoukhrat Mitalipov Lab

Footage from Shoukhrat Mitalipov's lab at OHSU. (OHSU/Sara Hottman)

Paula Amato, M.D., and Shoukhrat Mitalipov, Ph.D.

Paula Amato, M.D., professor of obstetrics and gynecology in the OHSU School of Medicine, and Shoukhrat Mitalipov, Ph.D., director of the OHSU Center for Embryonic Cell and Gene Therapy. (OHSU/Christine Torres Hicks)

Paula Amato, M.D. (OHSU)

Shoukhrat Mitalipov, Ph.D.

Shoukhrat Mitalipov, Ph.D., director of the OHSU Center for Embryonic Cell and Gene Therapy. (OHSU/Christine Torres Hicks)

Shoukhrat Mitalipov, Ph.D.

Study reveals limitations in evaluating gene editing technology in human embryos

Gene editing technologies hold promise in preventing and treating debilitating inherited diseases, however new research from Oregon Health & Science University reveals limitations that must be overcome before gene-editing to establish a pregnancy can be deemed safe or effective. (OHSU/Sara Hottman)